The U.S. Food and Drug Administration has granted orphan drug status to Kind Pharmaceuticals’ investigational oral small molecule AND017 to treat sickle cell disease (SCD). This designation is granted ...

The FDA has cleared Iterum’s oral an­tibi­ot­ic for cer­tain pa­tients with un­com­pli­cat­ed uri­nary tract in­fec­tions (uUTIs) who have lim­it­ed or no al­ter­na­tive oral op ...

patients have previously needed to receive treatment in hospital settings, an Iterum spokesperson explained over email. As an oral alternative to a proven antibiotic, Orlynvah will likely be ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28 th ...

“As the first oral penem approved in the U.S., ORLYNVAH™ offers an excellent alternative treatment option for appropriate patients in the underserved uUTI market. With FDA approval and a ...

You’ve probably given someone the silent treatment once or twice (or maybe even more than that). You know the drill — you and your partner get into a heated argument that ends with hurt feelings and ...

Ahead of an Antimicrobial Drugs Advisory Committee meeting last month, FDA reviewers voiced ongoing concerns about the benefits versus the risks of the oral treatment, including its potential for ...

“As the first oral penem approved in the U.S., ORLYNVAH™ offers an excellent alternative treatment option for appropriate patients in the underserved uUTI market. With FDA approval and a clear label, ...

Board-certified nurse practitioner Katie Zimmerman, NP-C, who is also expecting, agrees, adding that oral skincare ... pregnant patients seek treatment for are acne and melasma.

Though I'm meticulous with my use of retinoids and vitamin C, The Problem Solver Brightening Treatment has been the cherry on top of maintaining a melasma-free face all year long. It has a creamy ...